Overall, the researchers concluded that the beta-glucan supplement consistently stimulated immune cells throughout the study which suggests that daily intake augments acquired immunity.
A recent pilot study1 found that supplementation with a branded beta-glucan, called PureMune from Immudyne Nutritional (Jacksonville, FL), helped reduce the risk of upper respiratory tract infection. In the study, 12 healthy subjects receive 30 mg of beta-glucan daily for 90 days during flu season. Subjects were examined at baseline, 30 days, 60 days, and 90 days.
Results showed that supplementation with the beta-glucan reduced the number of symptomatic upper respiratory infections by 44%, compared the same time period the previous year. For those that did get sick, supplementation reduced the duration of upper respiratory tract infections by 50%, compared to the previous year. Researchers also found that serum levels of IFN-γ, IL-2 and IFN-γ/IL-4 ratio increased significantly compared to baseline. Serum levels of IFN-γ were significantly higher at day 30, day 60 and day 90 while IL-2 levels were significantly higher at day 30 and day 60. The ratio of IFN-γ/IL-4 saw was significantly higher at day 30, day 60, and day 90.
Overall, the researchers concluded that the beta-glucan supplement consistently stimulated immune cells throughout the study which suggests that daily intake augments acquired immunity.
Reference
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.